Danazol, a New Steroidal Inducer of δ-AminolevulinicDanazol,Acid Synthetase

In: The Journal of Clinical Endocrinology & Metabolism · 1981 · vol. 52(3) , pp. 549–552 · doi:10.1210/jcem-52-3-549 · PMID:7462405 · W2131539052
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher

Abstract

Danazol (a derivative of 17 alpha-ethinyl testosterone) has recently been reported to cause clinical exacerbations of acute intermittent porphyria. In the present study, we demonstrate that danazol is an inducer of hepatic delta-aminolevulinic acid synthetase and that it increases hepatocyte porphyrin production using a chick embryo model. The findings provide an explanation for the clinical observations. Although danazol is a porphyrinogenic agent in the chick embryo and humans it has been reported to be ineffective as a porphyrinogen in rats. The present findings, therefore, also confirm the superiority of the chick embryo as a model system for the screening of drugs and chemicals which may have the potential to cause clinical exacerbations of porphyria.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T10:44:52.684890+00:00
License: CC0 · commercial use OK